MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinson’s Disease Burden in Underserved Populations Across the US in 2022

S. Kowal, K. Rosettie, E. Mearns, N. Win, H. Lin, B. Musch (South San Francisco, USA)

Meeting: 2024 International Congress

Abstract Number: 456

Keywords: Parkinson’s

Category: Epidemiology

Objective: To examine disparities in Parkinson’s disease (PD) burden by race or ethnicity, age, sex and region in the US.

Background: PD is the second most common age-related neurodegenerative disease in the US, and prior estimates of PD burden have varied. Individuals with PD of underrepresented racial and ethnic backgrounds may experience gaps and delays in accessing adequate care. Improved estimates of PD burden by race or ethnicity, age, sex and region are urgently needed.

Method: This secondary analysis used the Global Burden of Disease study, which included data on incidence, prevalence and deaths (hereafter named burden) in the US between January 1, 2022, and December 31, 2022. PD burden was evaluated by sex, age, race or ethnicity and region.

Results: Among the total age-standardized population, PD incidence per 100,000 (95% uncertainty interval) was 22.4 (13.7–35.0), prevalence was 180.1 (119.9–281.7) and the death rate was 10.0 (7.7–13.2) in 2022. PD burden was higher in men than women (male-to-female incidence, 2.0; prevalence, 1.9; deaths, 2.5) regardless of age, race or ethnicity and was highest in UT, MN and VT. Non-Hispanic White individuals had the highest PD burden (total US incidence, 24.8 [15.1–38.8]; prevalence, 199.1 [132.2–312.1]; deaths, 11.1 [8.5–14.5]) followed by Hispanic, American Indian or Alaskan Native, Asian or Pacific Islander, then Black individuals. PD incidence was highest in the group aged 75–84 years (187.4 [120.2–266.1]), whereas prevalence and deaths were highest in those aged ≥85 years (1739.1 [1055.4–3297.7] and 236.2 [162.3–343.8], respectively). While non-Hispanic White individuals had the highest PD burden nationally, Hispanic individuals had relatively high PD burden in HI, FL and the west (NM, AZ, CO, TX and WY). American Indian or Alaskan Native individuals had the highest incidence and prevalence in AK but the highest deaths in ME; PD burden was also relatively high in RI and CO. Among Asian or Pacific Islander individuals, the highest PD burden was in Washington, DC, HI, AZ and VA. Finally, considering only Black individuals, the highest PD burden was in Washington, DC and the west (CO, NV and AZ).

Conclusion: In 2022, non-Hispanic White men had the highest PD burden. Variable burden was observed by age, race or ethnicity and region, highlighting possible barriers to equitable access to care and the need for tailored intervention.

To cite this abstract in AMA style:

S. Kowal, K. Rosettie, E. Mearns, N. Win, H. Lin, B. Musch. Parkinson’s Disease Burden in Underserved Populations Across the US in 2022 [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/parkinsons-disease-burden-in-underserved-populations-across-the-us-in-2022/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsons-disease-burden-in-underserved-populations-across-the-us-in-2022/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley